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Allograft  survival  is  markedly  prolonged  by  a  variety  of pretreatment  regimens 
such  as  lymphocytotoxie  drugs,  irradiation,  and/or  culture  of donor  tissue.  These 
procedures,  initially  applied  to  the  thyroid  (1,  2)  and  subsequently  to  islets  of 
Langerhans,  stress the role of passenger lymphoid cells in allograft rejection.  Marked 
prolongation  of islet  allograft  survival  (>100  d)  across  a  major  histoeompatibility 
barrier has recently been accomplished  in rats by in vitro culture of islets at 24°C for 
7  d  before transplantation  in  conjunction  with  a  single  injection  of rabbit  anti-rat 
lymphocyte  serum  into  the  recipient  (3,  4).  Successfully  transplanted  islets  were 
promptly rejected  after  injection  of donor  lymphoid  cells  (5).  Thus,  cultured  islets, 
although  deficient  in  the  capacity  to  stimulate  allograft  rejection,  are  capable  of 
serving as the targets of an established  response. 
A  recent study with immunoferritin  labeling of fixed and  trypsin-dispersed  mouse 
islet cells concluded  that these cells lack all H-2 antigens  (6). Because only brain and 
ova of adult  animals  have  been  shown  to  lack  H-2  antigens  completely,  we  have 
repeated these studies with a  more conventional assay for histocompatibility antigens. 
20 anti-H-2 and anti-Ia sera have been tested on islet cells from mice of three different 
H-2 haplotypes by direct microcytotoxicity and by absorption. Contrary to the results 
of Parr (6), we find both H-2K and H-2D, but not Ia, antigens on the majority of islet 
cells. 
Materials  and  Methods 
Animals.  A/,J and B 10.AKM mice of either sex were obtained from The Jackson Laboratory, 
Bar Harbor, Maine. BALB/c mice were obtained from The `jewish Hospital of St. Louis, Mo. 
Islet Isolation and Culture.  Islets were isolated by the collagenase technique  (7). The method 
was modified for mouse islets by directly injecting the pancreas at numerous sites with Hanks' 
balanced salt solution  (HBSS).  10-15 mice were used for each isolation, with a  yield of ~50 
islets/mouse.  Isolated  islets  were separated  on  a  Ficoll  (Pharmacia  Fine  Chemicals,  Div. of 
Pharmacia, Inc., Piscataway, N. J.) gradient  (8).  To distinguish  islets from lymph nodes and 
other contaminating structures, the reflected green light technique (9) was used, and islets were 
hand picked with a dissecting microscope. They were then maintained in culture medium (8) 
in 5% CO2 for 1 or 2 d before being pooled on the 3rd d for dispersion. 
Dispase Dispersion oflslets.  Following exactly the procedure as described by Ono et al. (10), 
with Dispase (C,  odo Shusei, Ltd., Tokyo, `japan), -400 viable cells/islet were obtained, and the 
aldehyde-fuchsin stain (11) revealed that 85% of the cells were fl-cells. The dispersed cells were 
maintained for 6 or 24 h at 24 ° or 37°C before the microcytotoxicity test. 
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Mechanical Dispersion oflslets.  Pooled islets were collected by centrifugation and treated 3 
rain with 1 ml of 0.04%  EDTA at room temperature. The islets were centrifuged at high speed 
for  1 min  and  resuspended into Ca  +2- and  Mg+2-free balanced salt solution for mechanical 
disruption into  a  single-cell suspension.  This  was  accomplished by  gentle agitation with  a 
Pasteur pipet under a  dissection microscope. The agitation was stopped when  islets were no 
longer visible. 
Microcytotoxicity Test.  A two-stage microcytotoxicity test (12,  13), modified for islet cells, was 
used to assess H-2 and Ia antigens on enzymatically dispersed islet cells. The incubation with 
antiserum was shortened to 10 rain. For complement, a mixture of 3% agarose-absorbed rabbit 
serum and  20%  guinea pig serum  (pooled, fresh frozen, Grand Island Biological Co., Grand 
Island, N. Y.) was used. 
Antiserafor Microcytotoxicity Test.  Two anti-H-2 antisera (D13 and D30) were supplied by the 
Transplantation and Immunology Branch, National Institute of Allergy and Infectious Diseases, 
Bethesda Md.  All other anti-H-2 and  anti-Ia anlisera were produced in the Department of 
Genetics, Washington University School of Medicine, St. Louis, Mo. Each antiserum has been 
tested in the microcytotoxicity test against lymphocytes from a panel of strains representing 30 
independent and recombinant H-2 haplotypes to determine the H-2 or Ia specificities detected 
(Miroslav Hauptfeld. Personal communication.). 
Absorptions.  Antisera were absorbed with both enzymatically and  mechanically dispersed 
islets.  The antisera were diluted in HBSS cytotoxicity test medium to a  dilution twofold less 
than that at which a  decline in the titration curve began.  2.5  ×  10  ~ enzymatically dispersed 
islet cells (or 2.5-30 X  10  ~ splenocytes as positive absorption controls) were added to  10/d of 
this  diluted  antiserum,  and  the  suspension  was  incubated  1 h  at  room  temperature  with 
frequent shaking. Alternatively, 2.5 ×  105 mechanically dispersed islet cells were incubated first 
with 10 #1 of diluted anti-H-2 serum for 30 min. The cells were removed by centrifugation, and 
the  absorbed  serum  was  tested  in  the  microcytotoxicity assay.  Control  sera  were  treated 
similarly, but without addition of cells. 
Results 
Initial results of microcytotoxicity tests with BALB/c islet cells cultured for 6  h  at 
24°C  after dispersion are presented in Table I. Antisera directed against the H-2D  d 
antigen  killed the majority of the cells. Cross-reactive antisera,  detecting public H- 
2D  d specificities, gave lower but significant killing. Antisera reactive with the H-2K  d 
antigen effected a  very weak killing (18-25% cell death), whereas anti-Ia sera gave no 
killing above background, which indicated an absence from islet cells of determinants 
controlled by either the I-A or I-E/C subregions. 
To  evaluate  the  possibility that  the  islet  cells  failed  to  express  H-2K  d  and  Ia 
antigens because of degradation  by Dispase, splenocytes were  treated  with  Dispase 
under conditions identical to those used for islets, then incubated at room temperature 
for 2, 4, 5, and 6 h  and compared with untreated splenocytes in the microcytotoxicity 
assay.  No  difference  in  expression  of H-2K  or  H-2D  antigens  was  found  between 
treated  and  control  groups  after  any  time  interval,  but  Ia  antigen  expression  on 
treated splenocytes was initially low and did not return to control levels until 5 h  after 
treatment  (data not shown). 
These  results  suggested  that  the  failure  to  detect  H-2K  d  and  Ia  antigens  on 
BALB/c islet cells could be a result of the Dispase treatment and that the 6-h recovery 
period  at  room  temperature  might  be  insufficient  for  full  H-2  and  Ia  antigen 
expression on  islet cells. Consequently,  the effect of incubation at  37°C  for 6  h  was 
evaluated (Table II). It is clear that BALB/c islet cells incubated at 37°C for 6 h were 
more susceptible to killing by anti-H-2K  d sera than  those held at room temperature 
(Table  II  A).  However,  tests  with  anti-Ia  serum  remained  negative.  The  higher 
temperature of incubation thus enhanced H-?K  d but not Ia expression. FAUSTMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Results of Micmcytotoxicity Assays of BALB/c Islet Cells 
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Antiserum  Detects 
Percent dead cells  at anti- 
serum dilution* 
1:2  1:4  1:8 
(SJL ×  BI0) anti-B10.S(24R)  H-2D  d  68  65  45 
(BI0 ×  LP.RIII) anti-BlO.A(5R)  H-2D  d  80  70  70 
(SJL ×  B6) anti-B10.S(24R)  H-2D  d  70  70  65 
(A.SW ×  BI0.AKM) anti-A.TH  H-2D  d  70  70  60 
C3H.B10 anti-Bl0.D2  H-2D  d +  H-2K  d  80  78  60 
C3H anti-A.SW  H-2D  d (public)  35  30  22 
B10.OH anti-A.SW  H-2D  d (public)  50  50  40 
(A ×  BI0) anti-BlO.D2  H-2K  d +  I  d  18  18  15 
(A X BI0.A) anti-Bl0.D2  H-2K  d +  I  d  20  10  10 
(C3H.BI0 ×  BI0.A) anti-BI0.D2  H-2K  d +  i d  25  25  20 
(BI0.LG ×  A.TFR4) anti-BI0.D2  I  d  12  12  12 
(BI0.LG ×  BI0.M[IIR]) anti-Bl0.D2  I  d  12  12  12 
(Bl0 X D2.GD) anti-BlO.BDRl  I-E/C  'd  15  20  20 
(A X BI0.A) anti-B10.A(5R)  I-A  d  18  12  15 
(AKR.M ×  C3H.BI0) anti-C3H.Q  I-A  d  12  12  12 
* Background (normal mouse serum plus complement) was  10-15%  dead cells.  Each percentage 
value is the mean of two to three experiments. Variations in kill from one experiment to another 
did not exceed 5%. 
TABLE  II 
Results of Microcytotoxicity Assays of Islet Cells Allowed to Recover  for 6 h at Two Different Temperatures 
After Dispersion 
Antiserum  Detects 
Percent dead cells after recovery at* 
24°C  37°C 
1:2  1:4  1:8  1:2  1:4  1:8 
%  % 
A.  BALB/c islets  (H-2  d) 
(SJL ×  B10) anti-B10.S(24R)  H-2D  d  80  65  65  95  85  75 
C3H anti-A.SW  H-2D  d (public)  48  30  18  48  30  20 
(A ×  BI0) anti-Bl0.D2  H-2K  d +  I  d  25  25  18  65  60  55 
(A ×  BI0.A) anti-Bl0.D2  H-2K  d +  I  d  20  22  18  45  35  30 
(C3H.BI0 X BI0.A) anti-Bl0.D2  H-2K  d +  I  d  52  42  20  68  50  22 
(BI0.LG x  A.TFR4) anti-Bl0.D2  I  n  12  12  12  18  18  18 
B.  A/J islets  (H-2  °) 
(SJL ×  BI0) anti-B10.S(24R)  H-2D  d  80  80  80  85  82  85 
(BI0 ×  CR) anti-Bl0.K  H-2K  k +  I  s  75  78  68  75  75  70 
(129 ×  A.TL) anti-A.AL  H-2K  k  75  70  70  75  80  80 
(BI0.D2 ×  HTG) anti-Bl0  H-2K  k (public)  45  45  40  70  68  60 
A.TH anti-A.TL  I  k  15  15  15  12  15  12 
C.  BI0.AKM islets  (H-2  m) 
(BI0.A ×  LP.RIII) anti-Bl0.AKM  H-2D  q  85  85  85  90  90  90 
(BI0.A ×  LP.RIII) anti-Bl0.A(5R)  H-2D  q (public)  80  80  70  95  90  90 
(BI0 ×  CR) anti-Bl0.K  H-2K  ~ +  I  k  65  70  65  90  90  80 
(129  ×  A.TL) anti-A.AL  H-2K  k  70  60  30  90  90  85 
A.TH anti-A.TL  I  k  20  20  20  20  20  20 
* Background (normal mouse serum plus complement) was 15-'2~ dead cells.  Each percentage value is the mean of two 
experiments. 
Cells  from  two  more  inbred  strains  were  then  assayed  with  several  additional 
antisera.  Both A/J and BI0.AKM islet  cells, cultured  for 6  h  at either  24 °  or 37°C 
were killed by both the anti-H-2D and the anti-H2K sera (Table IIB and C). Again, 
somewhat  greater  killing was seen  after  a  37°C  incubation,  and  no reactivity  with 6O 
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Fro.  1.  (Left)  Reactivity  of  anti-Ia  serum  (A.TH  anti-A.TL)  after  absorptions  with  Dispase- 
dispersed  islet cells and spleen  cells from BI0.A  mice.  Residual  activity was assayed  by microcyto- 
toxicity  against  B10.A  spleen  cells.  (I-1)  Unabsorbed  control;  (I)  absorbed  with  2.5  ×  10 s  islet 
cells; (A) absorbed with 2.5 ×  10 s spleen cells;  (A) absorbed with 5 X  106 spleen cells;  (O) absorbed 
with  106 spleen cells;  (0)  absorbed with 3 ×  106 spleen cells. 
Fro.  2.  (Right)  Reactivity  of anti-Ia  serum  (A.TH  anti-A.TL)  (left  panel)  and  of anti-H-2D a 
serum  [(SJL  ×  B10)  anti-B10.S(24R)]  (right  panel)  after absorption  with  2.5  ×  10  s  mechanically 
dispersed B 10.A islet cells. Residual activity was assayed by microcytotoxicity  against  B10.A spleen 
cells.  (A) Absorbed  with islets;  ([5])  unabsorbed,  incubated  without  cells;  (')  unabsorbed,  freshly 
diluted. 
anti-Ia sera was detected.  Even longer recovery periods  (24 h  at 37°C)  did not result 
in killing above background by anti-Ia sera (data not shown). 
Finally,  two  absorption  analyses,  one with  Dispase-dispersed  islets  and  one with 
mechanically dispersed islets were conducted. Dispase-dispersed B 10.A islet cells failed 
to absorb the Ia antiserum, whereas the same or larger numbers of B 10.A splenocytes 
absorbed  anti-Ia activity  for B10.A  splenocytes  (Fig.  1).  To  test  the possibility  that 
islet  cells  express  Ia  antigens  that  are  stripped  by  Dispase  and  not  restored  to 
detectable  levels  under  our  treatment  conditions,  mechanically  dispersed  A/J  islet 
cells  were  consecutively  incubated  with  anti-Ia  serum  and  then  with  anti-H-2D d 
serum. These cells did not absorb activity from the anti-Ia serum, but did significantly 
reduce  the ability  of the anti-H-2D a serum  to kill  B10.A  splenocytes  (Fig.  2).  Both 
absorption experiments thus confirm the microcytotoxicity test results. 
Discussion 
By  direct  microcytotoxicity  testing,  we have demonstrated  the  presence of H-2K 
and H-2D  antigens on dispersed fl-cells  from murine islets of Langerhans,  but  have 
failed to detect  Ia antigens.  Our data indicate  that  Dispase treatment, necessary for 
dispersion of the cells, significantly reduces their H-2 reactivity and that an incubation 
period  of 6  h  at  37°C  is  necessary  for reexpression  of the  antigens.  This  raises  the 
possibility  that  Ia antigens  are also present  on  islet  cells  before  dispersion,  but  are 
stripped  by  the  treatment  and  are  restored  more  slowly  than  H-2  antigens.  Both 
prolonged  recovery  periods  and  absorption  with  mechanically  dispersed  islets  still 
failed to show I-region products. Clearly, islet cells lack detectable levels of Ia antigens. 
These results are in disagreement with a recent publication  (6), which reported the 
absence of H-2 antigens on fl-cells.  In that study,  trypsin-dispersed  islets were tested 
with only a  single alloantiserum potentially  reactive with products of the entire 11-2 FAUSTMAN El" AL.  BRIEF DEFINITIVE  REPORT  1567 
complex. The cells were examined only by electron microscopy after immunoferritin 
labeling.  The failure to detect  H-2 antigens could  have been a  result  of the loss of 
antigen  after  treatment  of islets  with  trypsin,  as  we  have  observed  with  Dispase 
treatment. Because the alloantiserum was diluted in normal rabbit serum (a source of 
complement), it is also possible that  the more strongly H-2-positive cells were lysed 
and eliminated before examination. 
The  ease  with  which  islets  of  Langerhans  can  be  transplanted  across  major 
histocompatibility barriers without rejection thus cannot be explained by the absence 
of major transplantation  antigens.  This  was  predicted  by  the  prompt  rejection  of 
established  allografts  upon  injection  of peritoneal  exudate  cells  (5).  Whereas  H-2 
antigens are present on the surfaces of nearly all adult nucleated cells (14), Ia antigens 
have been found to be expressed only on T  and B lymphocytes (15), macrophages (16, 
17), epidermal cells (16,  18), spermatozoa (16), intestinal epithelial cells (19, 20), and 
various products released by T  cells (21). Cells bearing Ia antigens have been directly 
implicated  in  a  variety of allograft  responses,  including  stimulation  of the  mixed- 
lymphocyte reaction and the graft-versus-host reaction (14, 22). It may be that culture 
of islets at 24°C  removes cells capable of stimulating an allograft rejection response. 
Future experiments will determine whether those cells bear Ia determinants. 
Summary 
Direct microcytotoxicity testing and absorption analyses were employed to deter- 
mine whether H-2K, H-2D, and Ia antigens are present on murine islet of Langerhans 
cells. Products of the H-2K and H-2D loci were found on fl-cells from three different 
mouse strains,  but/-region  (Ia) antigens were not detected.  The absence of Ia gene 
products  from  islet  cells  may be  of importance  in  explaining  the  survival  of islet 
allografts across major histocompatibility barriers. 
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